Trial intelligence / Profile preview

Cetaphil cream for prevention of atopic dermatitis in high-risk neonates

NCT00806221Phase 2Completed

Sponsor
Oregon Health & Science University
Start
Nov 2006
Primary completion
Nov 2008
Modality
Hydrogel Systems, Transdermal Patches
Countries
1
01

Overview

A Phase 2 trial of Cetaphil Healing Ointment in atopic dermatitis (AD), sponsored by Oregon Health & Science University. Started Nov 2006; status: completed.

02

Drugs

Cetaphil Healing Ointment
03

Conditions

atopic dermatitis (AD)

Beyond the preview

Go deeper on NCT00806221.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00806221.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call